Terms: = Ovarian cancer AND USP6, TRE2, 9098, ENSG00000129204, TRE17, Tre-2, HRP1
4 results:
1. Prediction Model of Residual Neural Network for Pathological Confirmed Lymph Node Metastasis of ovarian cancer.
Yao H; Zhang X
Biomed Res Int; 2022; 2022():9646846. PubMed ID: 36267845
[TBL] [Abstract] [Full Text] [Related]
2. Substantial lymphovascular space invasion predicts worse outcomes in early-stage endometrioid endometrial cancer.
Barnes EA; Martell K; Parra-Herran C; Taggar AS; Donovan E; Leung E
Brachytherapy; 2021; 20(3):527-535. PubMed ID: 33485810
[TBL] [Abstract] [Full Text] [Related]
3. Spectrum and frequencies of BRCA1/2 mutations in Bulgarian high risk breast cancer patients.
Dodova RI; Mitkova AV; Dacheva DR; Hadjo LB; Vlahova AI; -Hadjieva MST; Valev SS; Caulevska MM; Popova SD; Popov IE; Dikov TI; Sedloev TA; Ionkov AS; Timcheva KV; Christova SL; Kremensky IM; Mitev VI; Kaneva RP
BMC Cancer; 2015 Jul; 15():523. PubMed ID: 26183948
[TBL] [Abstract] [Full Text] [Related]
4. Antisense oligonucleotides to the epidermal growth factor receptor.
Witters L; Kumar R; Mandal M; Bennett CF; Miraglia L; Lipton A
Breast Cancer Res Treat; 1999 Jan; 53(1):41-50. PubMed ID: 10206071
[TBL] [Abstract] [Full Text] [Related]
